BRIEF-Clarus Therapeutics - Received Staff Determination Letter From Nasdaq Notifying That It Had Not Regained Compliance With Rules

Reuters2022-08-27

Aug 26 (Reuters) - Clarus Therapeutics Holdings Inc

* CLARUS THERAPEUTICS - ON AUGUST 22, CO RECEIVED STAFF DETERMINATION LETTER FROM NASDAQ NOTIFYING THAT IT HAD NOT REGAINED COMPLIANCE WITH RULES

* CLARUS THERAPEUTICS - UPON SUSPENSION FROM NASDAQ, CLARUS EXPECTS ITS SECURITIES TO BEGIN TRADING ON THE OTC MARKETS’ “OTC PINK MARKET” TIER

Source: [ Further company coverage:

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2262016903?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2022-08-27 04:23","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2262016903","market":"us","top_or_hot":-1,"title":"BRIEF-Clarus Therapeutics - Received Staff Determination Letter From Nasdaq Notifying That It Had Not Regained Compliance With Rules","media":"Reuters","content":"<html><body><p>Aug 26 (Reuters) - Clarus Therapeutics Holdings Inc</p><p> :</p><p>   * CLARUS THERAPEUTICS - ON AUGUST 22, CO RECEIVED STAFF DETERMINATION LETTER FROM NASDAQ NOTIFYING THAT IT HAD NOT REGAINED COMPLIANCE WITH RULES</p><p>   * CLARUS THERAPEUTICS - UPON SUSPENSION FROM NASDAQ, CLARUS EXPECTS ITS SECURITIES TO BEGIN TRADING ON THE OTC MARKETS’ “OTC PINK MARKET” TIER</p><p>Source: [ Further company coverage:   </p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Clarus Therapeutics - Received Staff Determination Letter From Nasdaq Notifying That It Had Not Regained Compliance With Rules</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Clarus Therapeutics - Received Staff Determination Letter From Nasdaq Notifying That It Had Not Regained Compliance With Rules\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-08-27 04:23 GMT+8&nbsp;&nbsp;&nbsp;<a href=http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Aug 26 (Reuters) - Clarus Therapeutics Holdings Inc :   * CLARUS THERAPEUTICS - ON AUGUST 22, CO RECEIVED STAFF DETERMINATION LETTER FROM NASDAQ NOTIFYING THAT IT HAD NOT REGAINED COMPLIANCE WITH ...</p>\n\n<a href=\"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"CGEM","symbol_name":"Cullinan Therapeutics","start_time":0,"source_url":"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","article_id":"2262016903","we_media_id":"1036604489","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2262016903","pubTimestamp":1661545393,"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"summary":"Aug 26 (Reuters) - Clarus Therapeutics Holdings Inc :   * CLARUS THERAPEUTICS - ON AUGUST 22, CO REC","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"CGEM":"Cullinan Therapeutics","QID":"纳指两倍做空ETF",".IXIC":"NASDAQ Composite","ON":"安森美半导体","BK4139":"生物科技","BK4007":"制药","BK4196":"保健护理服务","CRXT":"Clarus Therapeutics Holdings, Inc.","BK4082":"医疗保健设备","QLD":"纳指两倍做多ETF","SANA":"Sana Biotechnology, Inc.","BK4141":"半导体产品","LHDX":"Lucira Health, Inc.","QQQ":"纳指100ETF","SQQQ":"纳指三倍做空ETF","PSQ":"纳指反向ETF","BK4512":"苹果概念","TQQQ":"纳指三倍做多ETF","LABP":"Landos Biopharma, Inc.","APR":"Apria, Inc."},"translate_title":"简讯-Clarus Therapeutics-收到纳斯达克的员工决定信，通知它没有恢复遵守规则","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{".IXIC":0.9,"CRXT":0.9,"APR":0.65,"SANA":0.65,"CGEM":0.65,"ON":0.65,"LABP":0.65,"LHDX":0.65,"TQQQ":0.6,"SQQQ":0.6,"QQQ":0.6,"QLD":0.6,"QID":0.6,"PSQ":0.6,"NQmain":0.6,"MNQmain":0.6},"content_text":"Aug 26 (Reuters) - Clarus Therapeutics Holdings Inc :   * CLARUS THERAPEUTICS - ON AUGUST 22, CO RECEIVED STAFF DETERMINATION LETTER FROM NASDAQ NOTIFYING THAT IT HAD NOT REGAINED COMPLIANCE WITH RULES   * CLARUS THERAPEUTICS - UPON SUSPENSION FROM NASDAQ, CLARUS EXPECTS ITS SECURITIES TO BEGIN TRADING ON THE OTC MARKETS’ “OTC PINK MARKET” TIERSource: [ Further company coverage:","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.28.3","shortVersion":"4.28.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2262016903"}